Literature DB >> 32895171

[Clinical features of severe or critical ill patients with COVID-19].

Weidang Xie1, Shijie Zhu2, Yanan Liu1, Yujia Bai2, Weijun Fu1, Hui Chen1, Zhongqing Chen1, Jianwu Zhang2.   

Abstract

OBJECTIVE: To analyze the clinical features of severe or critical ill adult patients with coronavirus disease (COVID-19).
METHODS: The clinical data of 75 patients with severe or critical COVID-19 in Honghu People's Hospital from January to March in 2020 were collected.
RESULTS: Of the 75 patients with COVID-19 pneumonia, 41 were male (54.67%) and 34 were female (45.33%) with a mean age of 67.53 ±12.37 years; 43 patients had severe and 32 had critical COVID-19, and 49.3% of the patients had underlying diseases. The main clinical manifestations included fever (78.67%) and coughing (70.67%). Compared with the severe patients, the critically ill patients had higher proportions of patients over 60 years old with elevated white blood cell count, increased prothrombin time, and higher levels of hsCRP, PCT, D-dimer, ALT, LDH, cTnI and NT-proBNP. Univariate logistic regression analysis showed that an age over 60 years, leukocytosis, hs-CRP elevation, prolonged prothrombin time, and increased levels of D-dimer, NT-proBNP and cTnI were associated with severe COVID-19. Multivariate logistic regression showed that an age over 60 years (OR=8.165, 95% CI: 1.483-45.576, P=0.017), prolonged prothrombin time (OR=7.516, 95% CI: 2.568-21.998, P=0.006) and elevated NT-proBNP (OR=6.194, 95% CI: 1.305-29.404, P=0.022) were independent risk factors for critical type of COVID-19.
CONCLUSIONS: An age over 60 years, a prolonged prothrombin time and elevated NT-proBNP level are important clinical features of critically ill patients with COVID-19, and can be deemed as early warning signals for critical conditions of the disease.

Entities:  

Keywords:  COVID-19; clinical features; critical disease; pneumonia

Mesh:

Year:  2020        PMID: 32895171      PMCID: PMC7429169          DOI: 10.12122/j.issn.1673-4254.2020.08.07

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  13 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

Review 2.  The immunopathogenesis of sepsis in elderly patients.

Authors:  Steven M Opal; Timothy D Girard; E Wesley Ely
Journal:  Clin Infect Dis       Date:  2005-11-15       Impact factor: 9.079

3.  Predictors of mortality in Middle East respiratory syndrome (MERS).

Authors:  Ki-Ho Hong; Jae-Phil Choi; Seon-Hui Hong; Jeewon Lee; Ji-Soo Kwon; Sun-Mi Kim; Se Yoon Park; Ji-Young Rhee; Baek-Nam Kim; Hee Jung Choi; Eui-Cheol Shin; Hyunjoo Pai; Su-Hyung Park; Sung-Han Kim
Journal:  Thorax       Date:  2017-07-19       Impact factor: 9.139

4.  Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong.

Authors:  Kin Wing Choi; Tai Nin Chau; Owen Tsang; Eugene Tso; Ming Chee Chiu; Wing Lok Tong; Po Oi Lee; Tak Keung Ng; Wai Fu Ng; Kam Cheong Lee; William Lam; Wai Cho Yu; Jak Yiu Lai; Sik To Lai
Journal:  Ann Intern Med       Date:  2003-11-04       Impact factor: 25.391

5.  Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS).

Authors:  J W M Chan; C K Ng; Y H Chan; T Y W Mok; S Lee; S Y Y Chu; W L Law; M P Lee; P C K Li
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

6.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.

Authors:  Chaomin Wu; Xiaoyan Chen; Yanping Cai; Jia'an Xia; Xing Zhou; Sha Xu; Hanping Huang; Li Zhang; Xia Zhou; Chunling Du; Yuye Zhang; Juan Song; Sijiao Wang; Yencheng Chao; Zeyong Yang; Jie Xu; Xin Zhou; Dechang Chen; Weining Xiong; Lei Xu; Feng Zhou; Jinjun Jiang; Chunxue Bai; Junhua Zheng; Yuanlin Song
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

7.  Middle East Respiratory Syndrome.

Authors:  Yaseen M Arabi; Hanan H Balkhy; Frederick G Hayden; Abderrezak Bouchama; Thomas Luke; J Kenneth Baillie; Awad Al-Omari; Ali H Hajeer; Mikiko Senga; Mark R Denison; Jonathan S Nguyen-Van-Tam; Nahoko Shindo; Alison Bermingham; James D Chappell; Maria D Van Kerkhove; Robert A Fowler
Journal:  N Engl J Med       Date:  2017-02-09       Impact factor: 91.245

8.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

9.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.